Vertex Pharmaceuticals (VRTX) Minority Interest (2011 - 2018)
Vertex Pharmaceuticals (VRTX) posted quarterly Minority Interest of $28.4 million for Q3 2018, up 133.13% year-over-year from $12.2 million in Q3 2017, and down 1.01% quarter-over-quarter from $28.7 million in Q2 2018.
Vertex Pharmaceuticals (VRTX) Minority Interest (2011 - 2018) Analysis & Trends
Vertex Pharmaceuticals' Minority Interest history runs 8 years deep, the most recent figure standing at $28.4 million for Q3 2018.
- In Q3 2018, Minority Interest rose 133.13% year-over-year to $28.4 million; the TTM figure through Sep 2018 stood at $28.4 million (up 133.13% YoY), while the FY2017 annual figure was $13.7 million, down 92.44% from the prior year.
- Minority Interest for Q3 2018 stood at $28.4 million, down from $28.7 million in the prior quarter.
- The five-year high for Minority Interest was $196.0 million in Q2 2017, with the low at $12.2 million in Q3 2017.
- The 5-year median for Minority Interest is $153.5 million (2015), against an average of $106.9 million.
- The sharpest annual moves came in 2016 and 2017: Minority Interest surged 654.87% in 2016, then tumbled 93.49% in 2017.
- Vertex Pharmaceuticals' Minority Interest stood at $21.2 million in 2014, then surged by 625.6% to $153.7 million in 2015, then gained by 18.19% to $181.6 million in 2016, then plunged by 92.44% to $13.7 million in 2017, then surged by 106.64% to $28.4 million in 2018.
- Business Quant data shows VRTX's Minority Interest at $28.4 million in Q3 2018, $28.7 million in Q2 2018, and $29.8 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 28.37 Mn |
| Jun 30, 2018 | 28.66 Mn |
| Mar 31, 2018 | 29.77 Mn |
| Dec 31, 2017 | 13.73 Mn |
| Sep 30, 2017 | 12.17 Mn |
| Jun 30, 2017 | 195.96 Mn |
| Mar 31, 2017 | 182.79 Mn |
| Dec 31, 2016 | 181.61 Mn |
| Sep 30, 2016 | 186.80 Mn |
| Jun 30, 2016 | 187.49 Mn |
| Mar 31, 2016 | 159.12 Mn |
| Dec 31, 2015 | 153.66 Mn |
| Sep 30, 2015 | 154.59 Mn |
| Jun 30, 2015 | 153.25 Mn |
| Mar 31, 2015 | 21.08 Mn |
| Dec 31, 2014 | 21.18 Mn |
| Sep 30, 2013 | 182.17 Mn |
| Jun 30, 2013 | 187.00 Mn |
| Mar 31, 2013 | 191.85 Mn |
| Dec 31, 2012 | 196.67 Mn |